Biofourmis

AI-driven platform delivering hospital-at-home, remote patient monitoring, and in-home care across the full care continuum

Customer Engagement Growth Series D

Visit Website

Overview

Biofourmis is a healthcare technology company that enables hospitals, health systems, and payers to deliver acute and post-acute care in patients' homes. Founded in Singapore in 2015 by Kuldeep Singh Rajput and relocated to Boston in 2019, the company built its BiofourmisCare platform around FDA-cleared AI algorithms, wearable biosensors, and care coordination software to replace or supplement inpatient stays with home-based alternatives.

In October 2024 Biofourmis merged with CopilotIQ to form what the companies describe as the first end-to-end AI-driven platform for in-home care, spanning pre-surgical optimization through chronic care management. David Koretz, formerly CEO of CopilotIQ, leads the combined entity. In January 2025 Biofourmis sold its life science division (Biofourmis Connect) to ActiGraph, sharpening its strategic focus on care delivery for health systems and payers.

The company serves more than 50 health systems and payers across 25 US states and has published outcomes including a 70% reduction in 30-day readmissions, 21-hour earlier deterioration detection, and up to 38% reductions in cost of care.

Products & Services

BiofourmisCare Platform

End-to-end care delivery platform for health systems and payers, combining wearable biosensors, 21 proprietary FDA-cleared AI algorithms, and care coordination software. Captures 4M+ data points per post-acute care patient per day. Includes 70+ remote dynamic care pathways configured by disease, acuity level, and clinical goals.

Key Features

Medical-grade biosensor connectivity (device-agnostic)
Personalized AI baselines with early deterioration detection
Alert burden reduction up to 80% via notification optimization
EMR integration for documentation and billing
24/7/365 nursing and practitioner support network

Target Users: Hospital clinical teams, health system operations, payers

Hospital at Home (Biovitals Hospital@Home)

Acute care delivery in home settings, replacing inpatient stays. Platform licensed in 25 US states and aligned with the CMS Acute Hospital Care at Home program.

Key Features

Continuous vital sign monitoring via wearables
FDA-cleared AI deterioration detection
On-demand infusion, paramedicine, and mobile imaging coordination

Target Users: Health systems, hospitals

Timely Discharge

Transition management between care levels, enabling safe and earlier discharge from hospital to home. Reduces hospital length of stay.

Target Users: Hospital discharge planning teams, case managers

SNF at Home

Skilled nursing facility-level care delivered at home as an alternative to physical SNF placement.

Target Users: Health systems, payers

Remote Patient Monitoring

Continuous monitoring for chronic and high-acuity patients in home settings, with AI-driven alerts to clinical teams.

Target Users: Health systems, payers

At a Glance

Founded: 2015
Headquarters: Boston, MA, USA
Employees: 51-200
Funding: Series D

Category & Focus

Category: Customer Engagement
Subcategories: Remote patient monitoring hospital at home care coordination AI care management
Insurance Verticals: Health Group Benefits
Target Customers: Carriers, Employers